Biotech group Genentech scored a big victory as the U.S. Food and Drug Administration has granted a priority review of the company’s newest cancer-treating drug, Tecentriq. Read More »
The U.S. Food and Drug Administration has approved the use of Lucentis, created by biotech company Genentech, for people suffering with severe nearsightedness. Read More »
The public relations departments at American pharmaceutical manufacturers can’t be too pleased about the results of a new Harris Poll out this week that shows only nine percent of U.S. consumers believe “pharmaceutical and biotechnology companies put patients over profits.” Read More »
Two pharmaceutical giants — Sanofi and Regeneron — face a forced marketing shutdown of a high-priced cholesterol medication following a decision recently handed down by a U.S. District Court in Delaware ruling patent infringement of another medication. Read More »
Mylan N.V, a major distributor of over the counter medications, has acquired popular cold medication Cold-Eeze from ProPhase Labs Inc. Read More »
The U.S. Food and Drug Administration has approved Sangamo BioSciences Inc.'s Investigational New Drug Application for the SB-525 gene therapy program for patients with hemophilia A. Read More »
Custopharm Inc., a U.S. producer of generic injectable devices, has acquired two Paragraph IV abbreviated new drug application products from Perrigo Co. PLC. Read More »
The U.S. Food and Drug Administration granted orphan drug designation to Alexion Pharmaceuticals for ALXN1210, a drug for treating patients with paroxysmal nocturnal hemoglobinuria. Read More »
At the touch of a fingertip, Cigna enrollees can now track health information, find practitioners and manage claims, all via their digital devices, with the company’s recent installation of personalized fingerprint access to their accounts. Read More »
The Pharmaceutical Care Management Association (PCMA) recently started a campaign to promote pharmacy benefit managers (PBMs) and launched the related website DrugBenefitSolutions.com. Read More »
The U.S. Food and Drug Administration granted orphan drug designation to Acucela's leading drug candidate emixustat hydrochloride, which was created to treat Stargardt disease. Read More »
Dova Pharmaceuticals Inc., a clinical, late-stage company, recently named Alex Sapir as its new CEO. Read More »
Amorsa Therapeutics, a neuropharmaceutical company specializing in treating nervous system disorders, has entered a partnership with Janssen Pharmaceuticals Inc. Read More »
Ionis Pharmaceuticals Inc. and Akcea Therapeutics, an Ionis subsidiary, recently announced a partnership with Novartis to develop and commercialize the drugs AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx. Read More »
Dr. Ciara Kennedy has been named president and chief executive officer of Amplyx Pharmaceuticals, a company that develops novel antifungal agents for life-threatening fungal infections. Read More »
Expanding their existing relationship, Community Health Network will manage 12 retail health clinics in Walgreens stores across central Indiana. Read More »
Iroko Pharmaceuticals LLC, a company focused on advancing the science of analgesia, recently received a patent for VIVLODEX (meloxicam) capsules 5 mg and 10 mg. Read More »
The Centers for Disease Control and Prevention (CDC) recently announced 10 critical contributions toward the fight against the Zika virus in 2016. Read More »
RxWiki Inc. has launched Patient Verified Reviews, a platform that allows patients to rate their pharmacy. Read More »
EnteroMedics Inc. has retired its Senior Amortizing Convertible Notes, converted all $18.75 million in notes to shares of common stock, as part of a strategy to regain compliance with the Nasdaq requirement that it have a minimum of $2.5 million of stockholders’ equity. Read More »
Alerts Sign-up
